Macrophages as targets for delivery of liposome-encapsulated antimicrobial agents

Advanced Drug Delivery Reviews

Volumn 2, Issue 1, 1988, Pages 107-128

  Alving, Carl R ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Antimicrobial; Endosome; Leishmaniasis; Liposome; Macrophage

Indexed keywords

CEFALOTIN; DRUG CARRIER; LIPOSOME; MEGLUMINE ANTIMONATE; STREPTOMYCIN;

DOG; DRUG TARGETING; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLOSIS;

EID: 0023738953     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(88)90007-5     Document Type: Review

References (89)

1. Interaction between phagocytes and pathogenic microorganisms
2. The encounter of the microbe with the phagocytic cell
3. A comparative study of drug-metabolizing enzymes present in rat-liver parenchymal, Kupffer and endothelial cells
4. A new look at reticuloendothelial blockade
5. Control of spillover
6. The role of endotoxin in liver injury
7. Clinical aspects of Kupffer-cell failure in liver disease
8. Phagocyte strategy vs. microbial tactics
9. Fusion of host cell secondary lysosomes with parasitophorous vacuoles of Leishmania mexicana-infected macrophages
10. Multiplication of a human parasite (Leishmania donovani) in phagolysosomes of hamster macrophages in vitro
11. The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state
12. Migration of Kupffer cells
13. Quantitative analysis of total macrophage content in adult mouse tissues
14. The reticulo-endothelial system and blood clearance
15. The use of biocompatible microparticles as carriers of enzymes and drugs in vivo
16. Microparticulate drug carriers
17. Fate and behavior of liposomes in vivo: A review of controlling factors
18. Chronic liposome administration in mice: effects on reticuloendothelial function and tissue distribution
19. Macrophage heterogeneity
20. Interaction of liposomes with polymorphonuclear leukocytes
21. Antibody-dependent phagocytosis of haptenated liposomes by human neutrophils is dependent on the physical state of the liposomal membrane
22. Interaction of liposomes with human leukocytes in whole blood
23. Design of biodegradable polyalkylcyanoacrylate nanoparticles as a drug carrier
24. Polylysine-drug conjugates
25. Antilcishmanial activity of human red blood cells containing formycin A
26. Activity of immunoglobulin G-coated red-cell ghosts containing pentamadine against macrophage-contained Leishmania in vitro
27. Activity of pentamadine-containing human red cell ghosts against visceral leishmaniasis in the hamster
28. Liposomes and other drug delivery systems in the treatment of leishmaniasis
29. Delivery of liposome-encapsulated drugs to macrophages
30. Liposomes as drug carriers in leishmaniasis and malaria
31. Liposome-mediated treatment of viral bacterial, and protozoal infections
32. Liposomes in treatment of infectious diseases
33. Design of liposomes for enhanced local release of drugs by hyperthermia
34. pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact
35. Target-sensitive immunoliposomes as an efficient drug carrier for antiviral activity
36. Liposome therapy for experimental cutaneous and visceral leishmaniasis
37. Liposome-mediated drug delivery to mononuclear phagocytes in vivo: Applications in antimicrobial therapy
38. Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery
39. Investigation of the role of mononuclear phagocytes in the transportation of doxorubicin-containing liposomes into a solid tumor
40. Problems with leishmaniasis
41. The leishmaniases
42. Algorithms in the diagnosis and management of exotic diseases
43. Epidemiology and ecology of leishmaniasis in Latin-America
44. A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya
45. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)
46. American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules
47. The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis
48. Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs
49. Antileishmanial activity of antimonials entrapped in liposomes
50. Antileishmanial activity of liposome-encapsulated meglumine antimoniate in the dog
51. Therapeutic potential of liposomes as drug carriers in leishmaniasis, malaria and vaccines
52. Liposomes in leishmaniasis: effects of parasite virulence on treatment of experimental leishmaniasis in hamsters
53. Liposomes as drug carriers for treatment of leishmaniasis
54. Liposomes in the treatment of parasitic diseases
55. Liposomes in leishmaniasis: The lysosome connection
56. Liposomal chemotherapy in visceral leishmaniasis: An ultrastructural study of an intracellular pathway
57. Quantitative and ultrastructural studies on the uptake of drug loaded liposomes by mononuclear phagocytes infected with Leishmania donovani,
58. The aminoglycosides
59. Effect of neomycin on phosphoinositide labelling and calcium binding in guinea-pig inner ear tissues in vivo and in vitro
60. Ototoxicity of aminoglycosides correlated with their action on monomolecular films of polyphosphoinositides
61. Interaction of aminoglycoside antibiotics with phospholipid liposomes studied by microelectrophoresis
62. Interactions of aminoglycoside antibiotics with negatively charged lipid bilayers
63. Interaction of gentamycin and spermine with bilayer membranes containing negatively charged phospholipids
64. Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes
65. Enhanced intracellular killing of Staphylococcus aureus by canine monocytes treated with liposomes containing amikacin, gentamycin, kanamycin, and tobramycin
66. Enhanced activity of streptomycin and chloramphenicol against intracellular Escherichia coli in the J774 macrophage cell line mediated by liposome delivery
67. Preparation and properties of liposome-associated gentamycin
68. Liposome-trapped penicillins in growth inhibition of some penicillin-resistant bacteria
69. Liposomes as carrier for antibiotics: a comparative study on the immune response against liposome-encapsulated penicillin and other penicillin preparations
70. Gastroenterocolitis and enteric fever syndromes
71. Nontyphoidal salmonellosis
72. Typhoid fever
73. Incidence of salmonellosis in patients with AIDS
74. Liposome-encapsulated cephalothin in the treatment of experimental murine salmonellosis
75. Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes
76. Intraphagocytic killing of Salmonella typhimurium by liposome-encapsulated cephalothin
77. Listeriosis
78. Listeriosis in adults: a changing pattern
79. Listeria monocytogenes bacteremia in the acquired immunodeficiency syndrome (letter)
80. Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome
81. Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages
82. Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice
83. Unexpected tissue distribution of liposomes coated with amylopectin derivatives and successful use in the treatment of experimental legionnaires' diseases
84. Application of polysaccharide-coated liposomes in chemotherapy and immunotherapy
85. Treatment of brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides
86. Antibacterial activity of liposome-encapsulated streptomycin in mice infected with Mycobacterium tuberculosis
87. Effectiveness of various therapeutic regimens for bovine brucellosis